Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOZANTINIB S-MALATE Cause Rectal discharge? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Rectal discharge have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.0% of all adverse event reports for CABOZANTINIB S-MALATE.

7
Reports of Rectal discharge with CABOZANTINIB S-MALATE
0.0%
of all CABOZANTINIB S-MALATE reports
0
Deaths
1
Hospitalizations

How Dangerous Is Rectal discharge From CABOZANTINIB S-MALATE?

Of the 7 reports, 1 (14.3%) required hospitalization.

Is Rectal discharge Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB S-MALATE. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does CABOZANTINIB S-MALATE Cause?

Diarrhoea (8,282) Fatigue (6,819) Off label use (5,245) Nausea (4,341) Decreased appetite (4,076) Blood pressure increased (2,939) Malignant neoplasm progression (2,718) Palmar-plantar erythrodysaesthesia syndrome (2,706) Weight decreased (2,657) Stomatitis (2,560)

What Other Drugs Cause Rectal discharge?

ORLISTAT (475) ALLI (183) ADALIMUMAB (166) VEDOLIZUMAB (140) INFLIXIMAB (42) MESALAMINE (25) INFLIXIMAB-DYYB (23) OMEPRAZOLE (19) POLYETHYLENE GLYCOL 3350 (18) RANITIDINE (15)

Which CABOZANTINIB S-MALATE Alternatives Have Lower Rectal discharge Risk?

CABOZANTINIB S-MALATE vs CAFFEINE CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL CABOZANTINIB S-MALATE vs CALCIFEDIOL CABOZANTINIB S-MALATE vs CALCIPOTRIENE

Related Pages

CABOZANTINIB S-MALATE Full Profile All Rectal discharge Reports All Drugs Causing Rectal discharge CABOZANTINIB S-MALATE Demographics